BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38062709)

  • 21. APOBEC and ADAR deaminases may cause many single nucleotide polymorphisms curated in the OMIM database.
    Lindley RA; Hall NE
    Mutat Res; 2018 Jul; 810():33-38. PubMed ID: 29957488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data.
    Haricharan S; Bainbridge MN; Scheet P; Brown PH
    Breast Cancer Res Treat; 2014 Jul; 146(1):211-20. PubMed ID: 24839032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mismatch-mediated error prone repair at the immunoglobulin genes.
    Chahwan R; Edelmann W; Scharff MD; Roa S
    Biomed Pharmacother; 2011 Dec; 65(8):529-36. PubMed ID: 22100214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody diversification caused by disrupted mismatch repair and promiscuous DNA polymerases.
    Zanotti KJ; Gearhart PJ
    DNA Repair (Amst); 2016 Feb; 38():110-116. PubMed ID: 26719140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of APE1 and APE2 in germinal centers promotes error-prone repair and A:T mutations during somatic hypermutation.
    Stavnezer J; Linehan EK; Thompson MR; Habboub G; Ucher AJ; Kadungure T; Tsuchimoto D; Nakabeppu Y; Schrader CE
    Proc Natl Acad Sci U S A; 2014 Jun; 111(25):9217-22. PubMed ID: 24927551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal genetically detectable minimal residual disease by fluorescence
    Cui J; Yu T; Lv R; Liu J; Fan H; Yan W; Xu J; Du C; Deng S; Sui W; Ho M; Xu Y; Anderson KC; Dong X; Qiu L; An G
    Ther Adv Med Oncol; 2024; 16():17588359231221340. PubMed ID: 38249329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FAM72A antagonizes UNG2 to promote mutagenic repair during antibody maturation.
    Feng Y; Li C; Stewart JA; Barbulescu P; Seija Desivo N; Álvarez-Quilón A; Pezo RC; Perera MLW; Chan K; Tong AHY; Mohamad-Ramshan R; Berru M; Nakib D; Li G; Kardar GA; Carlyle JR; Moffat J; Durocher D; Di Noia JM; Bhagwat AS; Martin A
    Nature; 2021 Dec; 600(7888):324-328. PubMed ID: 34819670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted sequencing reveals the somatic mutation landscape in a Swedish breast cancer cohort.
    Mathioudaki A; Ljungström V; Melin M; Arendt ML; Nordin J; Karlsson Å; Murén E; Saksena P; Meadows JRS; Marinescu VD; Sjöblom T; Lindblad-Toh K
    Sci Rep; 2020 Nov; 10(1):19304. PubMed ID: 33168853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The biochemistry of somatic hypermutation.
    Peled JU; Kuang FL; Iglesias-Ussel MD; Roa S; Kalis SL; Goodman MF; Scharff MD
    Annu Rev Immunol; 2008; 26():481-511. PubMed ID: 18304001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A role for the MutL mismatch repair Mlh3 protein in immunoglobulin class switch DNA recombination and somatic hypermutation.
    Wu X; Tsai CY; Patam MB; Zan H; Chen JP; Lipkin SM; Casali P
    J Immunol; 2006 May; 176(9):5426-37. PubMed ID: 16622010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutational Analysis Identifies Therapeutic Biomarkers in Inflammatory Bowel Disease-Associated Colorectal Cancers.
    Din S; Wong K; Mueller MF; Oniscu A; Hewinson J; Black CJ; Miller ML; Jiménez-Sánchez A; Rabbie R; Rashid M; Satsangi J; Adams DJ; Arends MJ
    Clin Cancer Res; 2018 Oct; 24(20):5133-5142. PubMed ID: 29950348
    [No Abstract]   [Full Text] [Related]  

  • 32. A Novel AICDA Splice-Site Mutation in Two Siblings with HIGM2 Permits Somatic Hypermutation but Abrogates Mutational Targeting.
    Dirks J; Haase G; Cantaert T; Frey L; Klaas M; Rickert CH; Girschick H; Meffre E; Morbach H
    J Clin Immunol; 2022 May; 42(4):771-782. PubMed ID: 35246784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HMCES protects immunoglobulin genes specifically from deletions during somatic hypermutation.
    Wu L; Shukla V; Yadavalli AD; Dinesh RK; Xu D; Rao A; Schatz DG
    Genes Dev; 2022 Apr; 36(7-8):433-450. PubMed ID: 35450882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers.
    Bertucci F; Rypens C; Finetti P; Guille A; Adélaïde J; Monneur A; Carbuccia N; Garnier S; Dirix P; Gonçalves A; Vermeulen P; Debeb BG; Wang X; Dirix L; Ueno NT; Viens P; Cristofanilli M; Chaffanet M; Birnbaum D; Van Laere S
    Mol Oncol; 2020 Mar; 14(3):504-519. PubMed ID: 31854063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypermutation at A/T sites during G.U mismatch repair in vitro by human B-cell lysates.
    Pham P; Zhang K; Goodman MF
    J Biol Chem; 2008 Nov; 283(46):31754-62. PubMed ID: 18786917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatic hypermutation: activation-induced deaminase for C/G followed by polymerase eta for A/T.
    Neuberger MS; Rada C
    J Exp Med; 2007 Jan; 204(1):7-10. PubMed ID: 17190841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating tumor DNA analysis predicts recurrence and avoids unnecessary adjuvant chemotherapy in I-IV colorectal cancer.
    Fan W; Xia Z; Chen R; Lin D; Li F; Zheng Y; Luo J; Xiong Y; Yu P; Gao W; Gong Y; Zhang F; Zhang S; Li L
    Ther Adv Med Oncol; 2024; 16():17588359231220607. PubMed ID: 38282662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleotide insertions and deletions complement point mutations to massively expand the diversity created by somatic hypermutation of antibodies.
    Bowers PM; Verdino P; Wang Z; da Silva Correia J; Chhoa M; Macondray G; Do M; Neben TY; Horlick RA; Stanfield RL; Wilson IA; King DJ
    J Biol Chem; 2014 Nov; 289(48):33557-67. PubMed ID: 25320089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Genomics of next generation sequencing in pediatric B-acute lymphoblastic leukemia and its impact on minimal residual disease].
    Gao YY; Jia YJ; Qi BQ; Zhang XY; Chen YM; Zou Y; Guo Y; Yang WY; Zhang L; Wang SC; Zhang RR; Liu TF; Song Z; Zhu XF; Chen XJ
    Zhonghua Er Ke Za Zhi; 2023 Jun; 61(6):527-532. PubMed ID: 37312464
    [No Abstract]   [Full Text] [Related]  

  • 40. Integrity of immunoglobulin variable regions is supported by GANP during AID-induced somatic hypermutation in germinal center B cells.
    Eid MMA; Shimoda M; Singh SK; Almofty SA; Pham P; Goodman MF; Maeda K; Sakaguchi N
    Int Immunol; 2017 May; 29(5):211-220. PubMed ID: 28541550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.